Hodgkins and Non-Hodgkins Lymphome Flashcards
list the non-Hodgkins Lymphomas
Acute Lymphoblastic Leukemia
Mantle Cell Lymphoma
Follicular Lymphoma
Burkitt Lymphoma
Mantle cell lymphoma
B-cell neoplasm composed of monomorphic lymphocites w/ irregular nuclei
Express B-cell markers CD19, CD20, CD5
Express Cyclin1D+, CD1+, and BCL6+
BCL1 gene rearrangement at 11q13, constant overexpression of cyclin D1 t(11;14)(q13;32) involving BCL1 gene + IGH gene
Clinical features: Avg age of diagnosis: 60 yrs, M:F = 2:1. Localized mostly in lymph nodes. Pts present at stage 3-4 w/ lymphadenopathy, hepatosplenomegaly.
Hyalinized small vessels often present.
Moderately aggressive
Follicular lymphoma
Germinal center B-cell lymphoma
40% of adult lymphomas, age of onset 60 yrs. Pts mostly asymptomatic. Some have spleen enlargement, Waldeyer’s ring, GI tract, skin, and soft tissue involvement
Poorly defined mantle zone, lack of polarization. Have centrocytes and centroblasts.
Immunophenotype: CD19+, CD20+, BCL2+
Germinal center B-cells = CD10+ and BCL6+
Cytogenetics: t(14;18)(q32;q21) Placed BCL2 under promoter. Overexpression induces hyperplacia.
Burkitt Lymphoma
germinal center B-cell lymphoma
Highly aggressive, presents in extranodal sites or in leukemic form. Monomorphic medium sized B-cells w/ basophilic cytoplasm and high mitotic rt.
Clinical features: typical in malaria belt, 4-7 yrs of age, sporadic in children and young adults. Found in HIV pts as an immunodeficiency associated lymphoma.
Often found in jaw and facial bones (50%) others in distal ileum, cecum and omentum
Immunophenotype: CD19+, CD20+, high proliferation index (nearly 100% w/ Ki-67 staining,) EBV mostly positive
Cytogenetic findings: t(8;14)(q24;32) MYC gene next to IGH
VERY AGGRESSIVE but potentially cureable
CLL/SLL
CLL:mature lymphocytosis of > 5 x10^9/L, sustained over 3 months.
Monoclonal antibodies w/ mature phenotype. CD5+, weak CD22, weak CD11c
SLL: same thing but disease predominated is extramedullary sites.
Median age 65 yrs, M:F ratio 2:1. Most are aymptomatic.
Common genetic findings: Deletion of 13q14 (common + favorable) Trisomy 12 Deletion of 11q22-23 Deletion of 17p13 (adverse prognosis)
Prognosis:
Favorable: CD38-, ZAP70-, germline IGH@V, pre-germinal center
Unfavorable: opposite
List plasma cell myeloma subtypes
Multiple Myeloma
Monoclonal Gammopathy of Undermined Significance
Solitary plasmacytoma of bone
Extraosseos Plasmacytoma
Multiple Myeloma
bone marrow based, M-protein found in serum or urine
Diagnostic criteria: M-protein in serum or urine. Related organ or tissue impairment. Hypercalcermia, renal insufficiency, anemia, bone lesions (CRAB)
Pts=50yrs old. Bone pain most common symptom.
IgM M protein found in 55% of pts, anemia in 2/3 of patients
Blood smear: rouleax formation
Monoclonal Gammopathy of Undetermined Significance
Monoclonal immunoglobulin in serum or urine w/ no evidence of plasma cell myeloma
Probs a precursor to multiple myeloma, transformation 1.5% per year
Solitary Plasmacytoma of Bone
Localized tumor of the bone made of cells of multiple myeloma
Single bone lesion w/ monoclonal plasma cells
Extraosseos Plasmacytoma
localized plasma cell tumors that arise in tissues outside bone marrow.
Patients: 55 yrs, 2/3 are male
Usually occur in respiratory tract, nasal passages, sinuses, oropharynx and larynx
List the major subtypes of classical Hodgkin Lymphoma
Nodular Sclerosis Classical - most frequent, found in young adults, predominantly females. Occurs above diaphragm. Thickened lymph node capsule+lacunar cells
Lymphocite-Rich Classical - about 5% of CHLs. Nodular growth pattern, residual germinal centers.
Mixed Cellularity Classical - 20-25% of HL, children and older patients. Lack broad band of collagen.
Lymphocyte-depleted Classical - least frequent type. EBV+, aplastic and bizarre. A CRAPTON of Reed-Sternberg Cells
List and describe the two subtypes of Hodgkins Lymphoma
Nodular lymphocyte predominant subtype (NLPHL) - indolent malignancy, popcorn or lymphocyte predominant cell
CHL (Classical Hodgkins Lymphoma) - malignant cells are a minority. Reed-Sternberg Cells in appropriate inflammatory background. CD30+ and CD15+